BCAR
ClosedD. Boral ARC Acquisition I Corp.
Deal announced 2026-05-14
Closed 2026-08-27
Pulse
96
→Closed
0–100 vitality — and a read on how the book feels about this shell.
% done
100%
Path to close
Price
$5.67
Mkt 229.98M
What is Pulse?
SPAC Pulse measures the current vitality of a deal on a 0–100 scale. A new IPO starts near 50 — a healthy heart with room both ways. It is not weakening just because nothing has printed yet. Weakening is a tag for a slowing beat (stalling cadence), not a quiet shell. 10-Q / 10-K on time is a good beat; an NT is a deficiency. File the report late, then file the NT late, and Pulse falls — that is how public investors read whether management is on top of the shell. Filing recovers some of it. It never pretends the miss did not happen. When other new IPOs file that window on time, they are no longer equal — those shells are healthier. High readings mean the deal book is accelerating; low readings flag life-support risk. Full methodology lives on the desk.
Rate + Lead II · 25 mm/s
Pulse Timeline
Top trace is the Pulse rate. Bottom is the filing lead — R-wave when the rate lifts, QS when it slows. Height is the change.
- 07-07 Proxy card
- 07-29 EGM / vote
- 08-14 10-Q
- 08-27 Closed
- 08-27 Listing deficiency
- 10-07 Now
Auto interpretation · Lead II printoutConverted — PubCoPulse 96
Last-trade printed. Marks below are the history that got here. Pulse is at the finish.
Silent 70dBeats/90d 1Recent gap 11d
Marks on this strip
- 07-0179 ↑5S-4. Book opened. Amendment velocity starts here. +5
- 07-0791 ↑12DEFM14A. Card is in. Late-stage tell. +12
- 07-0795 ↑4Proxy card. Card is in. Late-stage tell. +4
- 07-2995 →0EGM / vote. Shareholders printed. Path is late, not leftover trust. unchanged
- 08-1495 →010-Q. Periodic report on time. unchanged
- 08-2796 ↑1Closed. Shares appeared. Pulse at the finish.
- 08-2796 →0Listing deficiency. Exchange notice that day. It belongs on this date, not today. Pulse does not double-haircut an already-slow book.
- 10-0796 →0Now. Closed. Rate holds at the finish.
Impression: combination closed. Historical Pulse stays on the strip. A later 8-K Item 2.01 does not reprint it.
Unconfirmed machine read · not medical advice · not financial advice
Redemptions
95.95%
Cash condition
At risk
Skin in the game
low
Target
early
8-K Item 5.07
Votes & leftover trust
Share counts as filed. Preliminary tenders do not move cash until they settle.
2026-07-29 · final
26,865,211 shares · 95.95%
95.95% of outstanding public shares redeemed at the EGM. Trust is a stub.
Historical context
Effective in the archive
Precedent from 35 names in the Pulse archive (closed, liquidated, and broken deals). Archive base rate is one input; live beat speed then moves Pulse. Not a forecast.
- Close rate
- 99%
- Median days left
- 8
- Archive n
- 35
After a proxy card / DEFM14A, similar deals closed in a median of 34 days (IQR 28–38). Literature close rate at that stage is about 96%.
Status
Closed
Exchange
—
Rights
No
Warrants
1/2
CIK
0002065779
IPO date
2025-07-31
Market cap
229.98M
Days to deadline
—
SEC tickers
BCAR, BCARU, BCARW
Sponsor
—
S-4 / F-4 filer
SPAC (typical)
Fiscal year
December 31
Next filing
10-Q 2026-11-14
Vote
—
Schedule
What is due next
- Fiscal year
- Ends December 31 · 10-K cover
- This window
- 10-Q due 2026-08-14 · filed
- Next due
- 10-Q 2026-11-14Period 2026-09-30
- Pulse
- +6
10-Q for period ended 2026-06-30, due 2026-08-14. 10-Q 2026-08-14 on time (+6).
On time with this window. Pulse stays even with the other new listings that filed.
Meetings
- 2026-07-06 · Meeting 2026-07-06 (held)
- 2026-07-29 · Meeting 2026-07-29 (held)
Price history
Delayed exchange prints — common, rights, units, warrants when listed. Last price is in the header. This tape does not move Pulse.
Loading quotes…
Loading chart…
S-4 study: rights conversion did not change across amendments for this name. See amendment impact
S-4 amendment timeline
Shrinking gaps mean the deal is progressing. The tag says whether that filing cleared a checklist, dropped a hurdle, or repriced the deal.
Merging company
On file
Exascale Labs Inc.
Close timing Q&A
On file
second quarter of 2026
Meeting Q&A
On file
Meeting Q on file.
Proxy card
On file
Form of proxy is in the exhibits. Late-stage tell.
10-Q / 10-K
On file
10-Q for period ended 2026-06-30, due 2026-08-14. 10-Q 2026-08-14 on time (+6).
Proxy card is in the exhibits. That is a late-stage tell.
Q&A · close
When is the Business Combination expected to be completed? A. It is currently expected that the Business Combination will be consummated in the second quarter of 2026. This date depends, among other things, on the approval of the proposals to be put to BCAR shareholders at the Extraordinary General Meeting. However, such meeting could be adjourned if the Adjournment Proposal is adopted by BCAR s shareholders at the Extraordinary General Meeting and BCAR elects to adjourn the Extraordinary General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the Extraordinary General Meeting. For a description of the conditions for the completion of the Business Combination, see The Business Combination Proposal Business Combination Agreement . Q. What interests do the Sponsor and BCAR s current officers and directors
Q&A · meeting
When and where will the Extraordinary General Meeting be held? A. The Extraordinary General Meeting will be held at 10:00 A.M., Eastern Time, on July 29, 2026 at the offices of Loeb amp; Loeb LLP, 345 Park Avenue, New York, NY 10154. Shareholders may attend the Extraordinary General Meeting in person or virtually by visiting www.proxydocs.com/BCAR. Q. Who is entitled to vote at the Extraordinary General Meeting? A. BCAR has fixed July 6, 2026 as the Record Date for the Extraordinary General Meeting. If you were a shareholder of BCAR at the close of business on the Record Date, you are entitled to vote on matters that come before the Extraordinary General Meeting. However, a shareholder may only vote his, her or its shares if he, she or it is present in person or is represented by proxy at the Extraordinary General Meeting. 26 Table of contents Q. How
Show 23 more filings
- 8-K2026-07-08
8-K
- 4252026-07-08
425
- DEFM14A2026-07-07
DEFM14A
S-4
S-4/A
S-4/A
- 4252026-05-27
425
- 8-K2026-05-27
8-K
- 8-K2026-05-19
8-K
- 4252026-05-19
425
- 10-Q2026-05-15
10-Q
S-4
- 8-K2026-04-29
8-K
- 4252026-04-29
425
- 10-K2026-03-16
10-K
- 8-K2026-01-13
8-K
- 4252026-01-13
425
- 10-Q2025-11-05
10-Q
- 10-Q2025-09-03
10-Q
- 8-K2025-08-19
8-K
- 8-K2025-08-18
8-K
- 8-K2025-08-08
8-K
- 8-K2025-08-05
8-K
Your notes
Saved on this device only.
Journal
On BCAR
Journal
Latest journal
2026-08-24
SAMO files Q1 10-Q, reports $28k net loss from Jan 27 inception to Mar 31
Pre-IPO period shows $21.8k cash, $50k sponsor note, and $574k total liabilities against $571k assets.
2026-08-31
BCCQ 425 outlines $2.3B Ursa Major combination, $1.6B pre-money
Form 425 communication filed 31 Aug 2026 discloses proposed business combination terms and PIPE.
2026-08-31
BCCQ 425 details proposed Ursa Major combination at $1.6B consideration
Form 425 filed August 31 communicates terms of the business combination with Ursa Major Technologies, Inc. Registration statement on Form S-4 to follow.
2026-08-31
BCCQ 425 outlines Ursa Major deal at $2.3 billion equity value
Form 425 communication filed Aug. 31 details proposed combination with Ursa Major Technologies and related PIPE commitments.
- BCCQ 425 files on proposed Ursa Major combinationBCCQ · 2026-08-31
- HVII 425: ONE Nuclear executes binding LOI for 2.88 GW Project CaymanHVII · 2026-08-31
- BREZ Audit Committee concludes May 14, 2026 balance sheet cannot be relied upon; restatement requiredBREZ · 2026-08-31
- OCAC dismisses YCM CPA INC., appoints HYYH CPA. LLCOCAC · 2026-08-31
- SAMO Units separate; Class A shares and warrants begin individual trading on NYSESAMO · 2026-08-31